Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $OGI.V) (CSE: $MWM.C) (TSXV: $EMH.V) (TSXV: $LABS.V)
Delta, Kelowna, BC –May 17, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/05171OGI-MWM-EMH-LABS.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast I look at a few of the day’s earlier announcements.
But first, in Washington, Gov. Jay Inslee recently signed a new law into effect which allows parents in Washington the ability to medicate their children with marijuana on school grounds.
House Bill 1095 only recognizes the application of certain products containing cannabinoids, such as oils and creams, which have a THC concentration of 0.3 percent or less and specifies a small number of medical conditions which a student must have in order to receive such treatment.
The new law, which will go into effect on July 30, is now being reviewed by the Washington State School Directors Association (WASDA), who is working to draft a complete set of policies and procedures for every school district in the state to follow - a common practice regarding most new statutes involving Washington’s public education system.
Organigram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., a leading licensed producer of cannabis, announced that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019. Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI". The Company's common shares will continue to trade on the OTCQX under the symbol "OGRMF" until market close on May 20, 2019.
In conjunction with this Nasdaq listing, Organigram's common shares will become DWAC/FAST eligible for U.S. shareholders.
"We are pleased to celebrate this significant company milestone," says Greg Engel, CEO, Organigram. "We are proud to have assembled a world-class team and facility that continues to deliver value to our shareholders. This listing will help us continue to demonstrate our commitment to dynamic growth."
Micron Waste Technologies Inc. (CSE: MWM) (OTC: MICWF), a leading developer of waste treatment systems for food and cannabis waste, has been awarded United States Patent and Trade Office (USPTO) intellectual property protection for its commercial organic waste digester unit. Micron's Application No.: 29/644,928 sought and won recognition for leading innovative technological features which enable the digester to efficiently process food and cannabis waste on a commercial scale. Micron's digester hardware is also protected by an Industrial Design Certificate of Registration from the Canadian Intellectual Property Office (CIPO).
The digester is integral to Micron's Organivore™ food waste processing system and Micron's Cannavore™ system, the first purpose-built green technology developed for the rapidly-growing cannabis industry.
"We are especially proud to have been awarded two US patents within the past six months – one for our innovative biotechnology formula for waste treatment - and now a second for our hardware," said Micron Chief Technology Officer Dr. Bob Bhushan. "Our innovations allow Micron to deliver solutions to process waste compliantly from several target sectors – food processing; cannabis cultivation; beer, wine and spirits; and other industries that generate organic waste."
Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) has shipped 6,000 40 ml units of its SYNC 25 CBD oil to the British Columbia Liquor Distribution Branch (BCLDB). The Emerald-branded pure CBD oil offers consumers a non-THC, smoke-free product alternative.
“We are pleased to offer our new Emerald-branded wellness product SYNC 25 to the recreational marketplace in British Columbia,” said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. “The introduction of SYNC 25 marks the next step in our product growth strategy to develop innovative and quality consumer products that respond to a growing demand while providing higher profit margins.”
The SYNC 25 CBD oil product was extracted by MediPharm Labs Inc., a wholly-owned subsidiary of MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF).
“Emerald’s success in bringing products to the market that address the significant consumer demand for CBD demonstrates how MediPharm Labs’ specialized expertise in extraction empowers our partner brands with an advanced oil strategy and a competitive advantage,” said Pat McCutcheon, Chief Executive Officer of MediPharm Labs. “We look forward to providing high-quality, pharmaceutical-like cannabis concentrates as Emerald expands on its product growth strategy in the future.”
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
